Abstract
Background: Glucagon-like peptide 1(GLP-1) receptor agonists are used in patients with type 2 diabetes as hypoglycemic drugs; a growing body of eviden......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
